Developmental and foliation changes due to dysregulation of adenosine kinase in the cerebellum.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
14 11 2023
Historique:
received: 10 07 2023
accepted: 09 11 2023
medline: 16 11 2023
pubmed: 15 11 2023
entrez: 14 11 2023
Statut: epublish

Résumé

Adenosine kinase (ADK), the major adenosine-metabolizing enzyme, plays a key role in brain development and disease. In humans, mutations in the Adk gene have been linked to developmental delay, stunted growth, and intellectual disability. To better understand the role of ADK in brain development, it is important to dissect the specific roles of the two isoforms of the enzyme expressed in the cytoplasm (ADK-S) and cell nucleus (ADK-L). We, therefore, studied brain development in Adk-tg transgenic mice, which only express ADK-S in the absence of ADK-L throughout development. In the mutant animals, we found a reduction in the overall brain, body size, and weight during fetal and postnatal development. As a major developmental abnormality, we found a profound change in the foliation pattern of the cerebellum. Strikingly, our results indicated aberrant Purkinje cells arborization at P9 and accelerated cell death at P6 and P9. We found defects in cerebellar cell proliferation and migration using a bromodeoxyuridine (BrdU)-based cell proliferation assay at postnatal day 7. Our data demonstrate that dysregulation of ADK expression during brain development profoundly affects brain growth and differentiation.

Identifiants

pubmed: 37963945
doi: 10.1038/s41598-023-47098-5
pii: 10.1038/s41598-023-47098-5
pmc: PMC10645999
doi:

Substances chimiques

Adenosine Kinase EC 2.7.1.20
Protein Isoforms 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

19831

Informations de copyright

© 2023. The Author(s).

Références

J Neurosci. 2004 Jan 21;24(3):692-701
pubmed: 14736855
Elife. 2021 May 11;10:
pubmed: 33973524
Eur J Neurosci. 2007 May;25(9):2705-12
pubmed: 17459107
Semin Fetal Neonatal Med. 2016 Oct;21(5):321-32
pubmed: 27160001
Development. 2006 May;133(9):1811-21
pubmed: 16571625
Dev Biol. 2014 Nov 1;395(1):167-81
pubmed: 25050931
Genesis. 2004 Mar;38(3):130-8
pubmed: 15048810
Biochem Biophys Res Commun. 2009 Oct 9;388(1):46-50
pubmed: 19635462
Neuron Glia Biol. 2008 May;4(2):91-9
pubmed: 19674507
J Neurosci. 2016 Nov 30;36(48):12117-12128
pubmed: 27903722
Nat Med. 2011 Jun;17(6):726-31
pubmed: 21623382
Brain Res. 1970 Oct 28;23(3):343-52
pubmed: 5478302
Brain Commun. 2020;2(1):fcaa017
pubmed: 32322821
Lancet Neurol. 2013 Apr;12(4):381-93
pubmed: 23518331
Neural Dev. 2007 Dec 03;2:26
pubmed: 18053187
Neuropharmacology. 2020 May 1;167:107741
pubmed: 31419398
Front Pharmacol. 2021 May 14;12:672182
pubmed: 34054547
J Neuropathol Exp Neurol. 2015 Mar;74(3):261-72
pubmed: 25668568
J Neurosci. 2010 Sep 29;30(39):13157-65
pubmed: 20881134
Eur J Neurosci. 2007 Dec;26(11):3237-52
pubmed: 18005073
Mol Genet Metab. 2021 Jan;132(1):38-43
pubmed: 33309011
Neuropsychol Rev. 2010 Dec;20(4):327-48
pubmed: 21042938
Brain Res. 1991 Aug 23;557(1-2):184-9
pubmed: 1747752
Nat Commun. 2017 Oct 16;8(1):943
pubmed: 29038540
Nat Genet. 2000 Sep;26(1):93-6
pubmed: 10973257
Eur J Paediatr Neurol. 2016 Jan;20(1):188-91
pubmed: 26507178
Eur J Hum Genet. 2015 May;23(5):633-8
pubmed: 24916641
Hum Genet. 2007 Mar;121(1):43-8
pubmed: 17120046
Nat Genet. 2012 Jun 24;44(8):941-5
pubmed: 22729223
Development. 2014 Nov;141(21):4031-41
pubmed: 25336734
Brain. 2005 Oct;128(Pt 10):2383-95
pubmed: 15930047
Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3915-20
pubmed: 22345561
J Physiol. 2009 Sep 15;587(Pt 18):4497-508
pubmed: 19651764
Neuroscience. 2006 Sep 29;142(1):125-37
pubmed: 16859834
Cancer Cell. 2019 Dec 9;36(6):582-596
pubmed: 31821783
Cardiovasc Res. 2021 Jan 21;117(2):561-575
pubmed: 32065618
Neuroscience. 2006;137(2):437-45
pubmed: 16289890
Nat Genet. 2009 Sep;41(9):1037-42
pubmed: 19668217
Brain Behav Evol. 2020;95(2):69-77
pubmed: 32784306
Front Mol Neurosci. 2016 Oct 20;9:99
pubmed: 27812320
Am J Hum Genet. 2011 Oct 7;89(4):507-15
pubmed: 21963049
Glia. 2012 Aug;60(8):1234-43
pubmed: 22700220
eNeuro. 2021 Jun 2;8(3):
pubmed: 33863781
J Clin Invest. 2013 Aug;123(8):3552-63
pubmed: 23863710
Adv Pharmacol. 2011;61:77-94
pubmed: 21586356
J Mol Neurosci. 2008 Nov;36(1-3):38-44
pubmed: 18409023
J Child Neurol. 2009 Oct;24(10):1310-5
pubmed: 19332571
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6985-90
pubmed: 11997462
Pharmacol Rev. 2013 Apr 16;65(3):906-43
pubmed: 23592612

Auteurs

Hoda M Gebril (HM)

Departement of Biomedical Engineering, School of Engineering, Rutgers University, Piscataway, NJ, 08854, USA. Hoda.Gebril@rutgers.edu.

Tho Lai (T)

Department of Neurosurgery, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, 08854, USA.

Denise E Fedele (DE)

Department of Neurosurgery, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, 08854, USA.

Amir Wahba (A)

Department of Neurosurgery, Robert Wood Johnson Medical School, Rutgers University, Piscataway, NJ, 08854, USA.
Chemistry Department, Faculty of Science, Damietta University, New Damietta City, 34518, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH